If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.

Drug prices are up for negotiation on 15 Medicare Part D prescription drugs, including popular weight loss drugs such as Ozempic.

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Such vulnerabilities reveal systemic weaknesses, especially when drugs like Wegovy should only be prescribed under close clinical supervision. A significant concern is the prescription of Wegovy ...

The Biden administration moved Friday to negotiate the prices Medicare pays for the blockbuster weight-loss drugs ... of a new Medicare initiative aimed at lowering prescription drug prices ...